Are Formulary Decision Makers Data Needs Being Met for Specialty Drugs?

This study targeted pharmacists and physicians involved with formulary decision making in order to assess the level of satisfaction of specialty drug formulary decision makers with regards to the strength of current available data sources and unmet needs regarding clinical, economic, and unpublished evidence. See more here. (Source: JMCP Volume 22 Issue (4), April 2016)

You might also be interested in:

HTA Whitepaper Discusses Resulting Value and Economic Benefits 04/16/2021
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
JMCP’s Call to Action in Addressing Racial Disparities in… 11/02/2020
IQVIA Collaborates with HealthCore to Advance Clinical… 09/08/2021
Influential Usage of Big Data and Artificial Intelligence in… 09/07/2021
HealthEconomics.Com’s Value and Evidence Marketplace Seeking… 02/22/2021
Understanding the Expanded Role of the Medical Affairs Professional 04/12/2021